Pathways: Supporting Mental Health and Quality of Life for People with Advanced Lung Cancer
Official title: Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment
Funded at University of Kentucky · NIH-11129695 · Data updated 2026-11-12
This project offers a new program called "Pathways" to help people with advanced lung cancer achieve their personal goals and improve their well-being during treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project start | July 25, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $573,726 |
| NIH project number | 5R01CA283929-03 |
| Project ID | NIH-11129695 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults aged 21 and older who are receiving treatment for advanced lung cancer and are interested in psychosocial support.
✕Less likely to help
Patients who do not have advanced lung cancer or are not seeking support for their mental health and quality of life during treatment may not receive direct benefit from this specific program.
What this research studies
Even with new medical treatments for advanced lung cancer, many patients still face challenges with their mental health and overall quality of life. This project recognizes that care needs to focus not just on survival, but also on helping patients live well. The "Pathways" program is designed to support you in pursuing important personal goals related to your family, social life, work, and hobbies. By focusing on hope and personal aspirations, this program aims to reduce feelings of disruption and enhance your mental health and daily living.
Why it matters
Potential benefit: If successful, this program could significantly improve the mental health and quality of life for individuals undergoing treatment for advanced lung cancer.
How similar studies have gone: Hope-based interventions are a promising approach, and this project aims to test the effectiveness of a novel program called "Pathways" in this specific patient group.
Where this research is happening
-
University of Kentucky
Lexington, United States Active
Researchers
- Principal investigator: Mclouth, Laurie — University of Kentucky
- Study coordinator: Mclouth, Laurie
Related research
Other NIH-funded projects on the same topics.
-
Pathways: a hopeful program to help advanced lung cancer patients pursue personal goals and improve well-being
A brief, hope-based program helps adults with advanced lung cancer stay connected to goals in family, work, and daily life to support mental health and quality of life during treatment.
-
A hope-based program to help lung cancer patients pursue personal goals and improve their mental health.
This study is testing a new program called 'Pathways' to help people with advanced lung cancer focus on their personal goals and improve their mental well-being while they receive treatment.
-
Spatial control of immunogenic cancer killing for locally advanced lung cancer
A new approach uses radiation-triggered nanoparticles to deliver cancer-killing drugs directly to lung tumors while sparing healthy tissue.
-
Predicting how function, thinking, and life quality change in older adults with advanced lung cancer
This project aims to better predict how older adults with advanced non-small cell lung cancer will fare in daily living, thinking, and overall well‑being during treatment.
-
Comprehensive genetic testing for advanced lung cancer
This project looks at how using wide genetic testing that checks hundreds of cancer genes might help people with advanced non-small cell lung cancer and influence care decisions and costs.
-
Inhalable treatment for advanced lung cancer using engineered Influenza A virus
This study is testing a new inhalable treatment for lung cancer that has spread, using a specially designed virus to help your body fight the cancer while keeping healthy cells safe, and it’s aimed at improving survival for patients like you.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.